This interaction between 14-3-3ε and CD13, leading to a chondrocyte catabolic phenotype similar to that observed in osteoarthritis, could be a new target for treatment of osteoarthritis and could be investigated in preclinical studies. The gene discussed is ANPEP; the disease is osteoarthritis.